PDA001

· Celularity Incorporated

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for PDA001, covering 2018-03-01 to 2026-07-07. Get the full timeline:

Most recent: Clinical Trial Results: PDA001 for the Treatment of Adults With Moderate-to-Severe Crohn's Disease [Phase 2]